Biocryst Pharmaceuticals News and Activities

Presence

BioCryst Pharmaceuticals develops and sells medicines for rare and infectious diseases. Its products and research services focus on oral and injectable therapies for patients, healthcare providers, and hospital systems.

Biocryst Pharmaceuticals products and services overview:

Rare disease medicines
Antiviral therapies
Oral treatments
Injection therapies
Drug discovery

Revenue: ~$520 million

Employees: 600

Headquarters: Durham, United States (USA)

Biocryst Pharmaceuticals is one of the...

Biocryst Pharmaceuticals is a company listed under the stock ticker BCRX (US).

They are in:

Biotechnology50%
Pharmaceuticals50%

Acquisition, funding and merger involving Biocryst Pharmaceuticals.

Biocryst Pharmaceuticals has announced the acquisition of Astria Therapeutics (posted on October 20 2025).

Executives

View the org chart displaying its 38 main executives

Most searched biographies at Biocryst Pharmaceuticals

Popular executive movements at Biocryst Pharmaceuticals

Sandeep Menon has joined the company as Chief Research and Development Officer (posted on April 6 2026).
Ron Dullinger, who was Senior Vice President, General Manager, Americas, is promoted to Chief Commercial Officer (posted on January 2 2026).

Create your alert
to follow the executive moves at Biocryst Pharmaceuticals.